Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.97
-0.08 (-7.62%)
At close: May 28, 2025, 3:59 PM
0.97
0.00%
After-hours: May 28, 2025, 04:00 PM EDT
-7.62% (1D)
| Bid | 0.97 |
| Market Cap | 4.23M |
| Revenue (ttm) | 84.87K |
| Net Income (ttm) | -6.58M |
| EPS (ttm) | -2.61 |
| PE Ratio (ttm) | -0.37 |
| Forward PE | -1.01 |
| Analyst | Buy |
| Ask | 1.03 |
| Volume | 107,146 |
| Avg. Volume (20D) | 171,390 |
| Open | 0.98 |
| Previous Close | 1.05 |
| Day's Range | 0.94 - 1.05 |
| 52-Week Range | 0.82 - 9.00 |
| Beta | 1.82 |
About VRAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+50%
Virax Biolabs shares are trading higher after the ...
Unlock content with
Pro Subscription
8 months ago
+9.65%
Virax Biolabs shares are trading higher after the company announced it extended its existing exclusive distribution agreement with Cosmos Health to market Mpox in real time through its PCR detection kits.
